IP Library › Granted Patent US 9,102,521
Granted Patent B2
US 9,102,521 · App. 12/308,207 · Granted Aug 11, 2015

Nanosensors and related technologies

Inventors: Charles M. Lieber (Lexington, MA); Ying Fang (Cambridge, MA); Fernando Patolsky (Rehovot, IL)
Assignee: President and Fellows of Harvard College
B82Y10/00C12Q1/6825G01N27/4145G01N27/4146C12Q2600/156H01L51/0049H01L51/0093
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,102,521
App. No.
12/308,207
Granted
Aug 11, 2015
Kind
B2
Abstract

The present invention generally relates to nanoscale wire devices and methods for use in determining nucleic acids or other analytes suspected to be present in a sample. For example, a nanoscale wire device can be used to detect single base mismatches within a nucleic acid (e.g., by determining association and/or dissociation rates). In one aspect, dynamical information such as a binding constant, an association rate, and/or a dissociation rate, can be determined between an analyte and a binding partner immobilized relative to a nanoscale wire. In some cases, the nanoscale wire includes a first portion comprising a metal-semiconductor compound, and a second portion that does not include a metal-semiconductor compound. The binding partner, in some embodiments, is immobilized relative to at least the second portion of the nanoscale wire, and the size of the second portion of the nanoscale wire may be minimized and/or controlled in some instances.

Claims (19)

1. An article, comprising:

a nanoscale wire comprising a first portion and a second portion laterally defined along the length of the nanoscale wire, the first portion consisting essentially of a single crystal of a transition metal silicide compound, the compound being stoichiometric, and the second portion comprising a semiconductor, having a length of less than 100 nm, and having immobilized relative thereto a binding partner of an analyte, wherein the first portion is free of the binding partner.

2. The article of claim 1 , wherein the transition metal comprises nickel.

3. The article of claim 1 , wherein the nanoscale wire is part of a FET.

4. The article of claim 1 , wherein the nanoscale wire further comprises a third portion being defined laterally along the nanowire, the second portion separating the first portion and the third portion, the third portion consisting essentially of a single crystal of the transition metal-semiconductor compound.

5. The article of claim 1 , wherein the second portion has a length of less than 50 nm.

6. The article of claim 1 , wherein the second portion has a length of less than 30 nm.

7. The article of claim 1 , wherein the second portion further comprises a binding partner to an analyte immobilized relative thereto.

8. The article of claim 7 , wherein the analyte is a nucleic acid.

9. The article of claim 7 , wherein the binding partner is a nucleic acid.

10. The article of claim 7 , wherein the article comprises a plurality of nanoscale wires, each comprising distinguishable nucleic acids immobilized relative thereto.

11. An article, comprising:

a sample exposure region able to hold a solution containing an analyte;

a nanoscale wire positioned at least partially adjacent to or within the sample exposure region, the nanoscale wire comprising a first portion and a second portion, each laterally defined along the nanoscale wire, the second portion comprising a semiconductor and having immobilized relative thereto a binding partner able to bind to the analyte contained in the solution, and the first portion being free of the binding partner and comprising a conductive transition metal silicide compound, the compound being stoichiometric,

wherein the binding partner is able to bind one or more molecules of the analyte, wherein the analyte, when bound to the binding partner, has a Debye screening length within the solution that is greater than the greatest dimension of the second portion of the nanoscale wire.

12. The article of claim 11 , wherein the analyte comprises a nucleic acid.

13. The article of claim 11 , wherein a single molecule of the analyte, when bound to the binding partner, has a Debye screening length than the greatest dimension of the second portion of the nanoscale wire.

14. The article of claim 11 , wherein the transition metal silicide compound consists essentially of a single crystal.

15. The article of claim 11 , wherein the nanoscale wire comprises the first portion, the second portion, and a third portion each laterally defined along the nanoscale wire, wherein the third portion is free of the binding partner and comprises a conductive transition metal-semiconductor compound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: LIEBER, CHARLES M.; FANG, YING; PATOLSKY, FERNANDO
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 026000/0943 →
Continuity (2)
Provisional Application 60812884 · Jun 12, 2006
Related Publication 20100087013A1 · Apr 8, 2010